Embodiments of the present invention relate in general to valve replacement. More specifically, embodiments of the present invention relate to prosthetic valves for minimally-invasive replacement of an atrioventricular valve.
Ischemic heart disease causes regurgitation of a heart valve by the combination of ischemic dysfunction of the papillary muscles, and the dilatation of the ventricle that is present in ischemic heart disease, with the subsequent displacement of the papillary muscles and the dilatation of the valve annulus.
Dilation of the annulus of the valve prevents the valve leaflets from fully coapting when the valve is closed. Regurgitation of blood from the ventricle into the atrium results in increased total stroke volume and decreased cardiac output, and ultimate weakening of the ventricle secondary to a volume overload and a pressure overload of the atrium.
For some applications of the present invention, a collapsible prosthetic valve is configured for implantation in and/or at least partial replacement of a native atrioventricular valve of a patient, such as a native mitral valve or a native tricuspid valve. The prosthetic valve is configured to assume a collapsed state for minimally-invasive delivery to the diseased native valve, such as by percutaneous or transluminal delivery using one or more catheters. The prosthetic valve comprises a collapsible flexible support, which is at least partially covered by a covering. The prosthetic valve is shaped so as to define a downstream skirt and an upstream annular skirt. The downstream skirt is configured to be placed at the native valve, such that the downstream skirt passes through the orifice of the native valve and extends towards, and, typically partially into, a ventricle. The downstream skirt typically pushes aside and presses against the native leaflets of the native valve, which are typically left in place during and after implantation of the prosthetic valve. The upstream annular skirt is configured to be placed around a native annulus of the native valve, and to extend at least partially into an atrium such that annular skirt rests against the native annulus.
There is therefore provided, in accordance with some applications of the present invention, apparatus including a prosthetic atrioventricular valve for coupling to a native atrioventricular valve, the prosthetic valve including:
a support frame;
a covering, which at least partially covers the support frame, the support frame and the covering being shaped so as to define a downstream skirt;
a plurality of prosthetic leaflets, coupled to at least one element selected from the group consisting of: the support frame and the covering; and
an elongated anchoring member, configured to be positioned around the downstream skirt in a subvalvular space, such that the anchoring member presses native leaflets of the native valve against the downstream skirt, thereby anchoring the prosthetic valve to the native valve.
For some applications, the elongated anchoring member is configured to be positioned completely around the downstream skirt.
For some applications, the prosthetic valve further includes a contracting housing shaped so as to define a channel therethrough, a first end of the anchoring member is fixed to the contracting housing, and a second end of the anchoring member passes through the channel.
For some applications, the prosthetic valve is configured to assume collapsed and expanded states.
There is further provided, in accordance with some applications of the present invention, apparatus including a prosthetic atrioventricular valve for coupling to a native atrioventricular valve, the prosthetic valve including:
a support frame;
a covering, which at least partially covers the support frame, the support frame and the covering being shaped so as to define a downstream skirt;
a plurality of prosthetic leaflets, coupled to at least one element selected from the group consisting of: the support frame and the covering; and
a plurality of subvalvular anchoring elements, coupled to the downstream skirt, and configured to anchor the prosthetic valve to the native valve by piercing native leaflets of the native valve, passing through to a subvalvular space, and applying a force against the ventricular surface of the native leaflets.
For some applications, the prosthetic valve is configured to assume collapsed and expanded states.
For some applications, each of the tissue coupling elements is shaped as an element selected from the group consisting of: a hollow needle, a solid needle, a rod, and a rectangular plate.
For some applications, the tissue coupling elements are configured to assume a curved shape when in resting states.
For some applications, the tissue coupling elements are shaped so as to define respective barbs.
For some applications, the tissue coupling elements include needles.
For some applications, the needles are configured to assume curved shapes when in resting states.
For some applications, the needles are shaped so as to define respective lumens, and the apparatus further includes an implantation tool, which includes a plurality of rigid rods initially positioned in the lumens, respectively, so as to at least partially straighten the needles.
For some applications, the needles include a shape memory alloy.
There is additionally provided, in accordance with some applications of the present invention, apparatus including a prosthetic atrioventricular valve for coupling at a native valve, the prosthetic valve including:
a support frame;
a covering, which at least partially covers the support frame, the support frame and the covering being shaped so as to define an upstream annular skirt;
a plurality of prosthetic leaflets, coupled to at least one element selected from the group consisting of: the support frame and the covering;
a plurality of longitudinal members, coupled to the upstream annular skirt at respective sites; and
a plurality of tissue anchors, configured to be guided along the longitudinal members, respectively, and to couple the upstream annular skirt to cardiac tissue in a vicinity of the native valve.
For some applications, the prosthetic valve is configured to assume collapsed and expanded states.
For some applications, the tissue anchors are configured to pass over the respective longitudinal members.
For some applications, the longitudinal members include respective wires, and the tissue anchors are configured to be guided along the respective wires.
For some applications, each of the tissue anchors includes a coupling element that is shaped so as to define a shape selected from the group consisting of: a helix, a spiral, a corkscrew, and a screw shaft.
For some applications, the longitudinal members are removably coupled to the upstream annular skirt at the respective sites.
For some applications, the prosthetic valve further includes a downstream skirt.
For some applications, the prosthetic valve further includes a ventricular anchoring assembly, which includes:
a ventricular tissue anchor; and
a ventricular longitudinal member, a first end of which is coupled to the support structure, and a second end of which is coupled to the ventricular tissue anchor.
There is further provided, in accordance with some applications of the present invention, a method including:
providing a prosthetic atrioventricular valve, which includes (a) a support frame, (b) a covering, which at least partially covers the support frame, the support frame and the covering being shaped so as to define a downstream skirt, (c) a plurality of prosthetic leaflets, coupled to at least one element selected from the group consisting of: the support frame and the covering, and (d) an elongated anchoring member;
placing the prosthetic valve at a native valve of a subject, such that the downstream skirt passes through an orifice of the native valve toward a ventricle of the subject: and
anchoring the prosthetic valve to the native valve by positioning the elongated anchoring member around the downstream skirt in a subvalvular space, such that the anchoring member presses native leaflets of the native valve against the downstream skirt.
For some applications, the prosthetic valve further includes a contracting housing shaped so as to define a channel therethrough, a first end of the anchoring member being fixed to the contracting housing, and a second end of the anchoring member passing through the channel, and anchoring further includes pulling on the second end of the anchoring member to tighten the anchoring member around the native leaflets.
For some applications, placing the prosthetic valve includes delivering the prosthetic valve to the native valve while the prosthetic valve is in a collapsed state in a catheter, and deploying the prosthetic valve from the catheter such that prosthetic valve assumes an expanded state.
There is further provided, in accordance with some applications of the present invention, a method including:
providing a prosthetic atrioventricular valve, which includes (a) a support frame, (b) a covering, which at least partially covers the support frame, the support frame and the covering being shaped so as to define a downstream skirt, (c) a plurality of prosthetic leaflets, coupled to at least one element selected from the group consisting of the support frame and the covering, and (d) a plurality of subvalvular anchoring elements, coupled to the downstream skirt;
placing the prosthetic valve at a native valve of a subject, such that the downstream skirt passes through an orifice of the native valve toward a ventricle of the subject; and
anchoring the prosthetic valve to the native valve by causing the subvalvular anchoring elements to pierce native leaflets of the native valve, pass through to a subvalvular space, and apply a force against the ventricular surface of the native leaflets.
For some applications, placing the prosthetic valve includes delivering the prosthetic valve to the native valve while the prosthetic valve is in a collapsed state in a catheter, and deploying the prosthetic valve from the catheter such that the prosthetic valve assumes an expanded state.
For some applications, placing includes placing the prosthetic valve such that the downstream skirt pushes aside and presses against the native leaflets.
For some applications, the needles are shaped so as to define respective lumens, and anchoring includes causing the subvalvular anchoring elements to pierce the native leaflets while a rigid rods are initially positioned in the lumens, respectively, so as to at least partially straighten the needles, and subsequently withdrawing the rods from the lumens.
There is further provided, in accordance with some applications of the present invention, a method including:
providing a prosthetic atrioventricular valve, which includes (a) a support frame, (b) a covering, which at least partially covers the support frame, the support frame and the covering being shaped so as to define an upstream annular skirt, (c) a plurality of prosthetic leaflets, coupled to at least one element selected from the group consisting of: the support frame and the covering, and (d) a plurality of longitudinal members, coupled to the upstream annular skirt at respective sites;
placing the prosthetic valve at a native valve of a subject, such that the upstream annular skirt rests against a native annulus of the native valve, and the longitudinal members extend into an atrium of the subject;
guiding a plurality of tissue anchors along the longitudinal members respectively; and
using the anchors, coupling the upstream annular skirt to cardiac tissue in a vicinity of the native valve.
For some applications, the method further includes decoupling the elongated members from the upstream annular skirt.
For some applications, the method further includes, after placing the prosthetic valve at the native valve and before coupling the upstream annular skirt to the cardiac tissue using the tissue anchors, temporarily anchoring the prosthetic valve to a ventricular wall of the subject using one or more ventricular cords.
For some applications, placing the prosthetic valve includes delivering the prosthetic valve to the native valve while the prosthetic valve is in a collapsed state in a catheter, and deploying the prosthetic valve from the catheter such that the prosthetic valve assumes an expanded state.
For some applications, placing the prosthetic valve includes placing the prosthetic valve at the native valve such that the longitudinal members pass through the catheter.
For some applications, the prosthetic valve further includes a downstream skirt, and placing includes placing the prosthetic valve at the native valve such the downstream skirt passes through an orifice of the native valve toward a ventricle of the subject.
For some applications, placing includes placing the prosthetic valve such that the downstream skirt pushes aside and presses against native leaflets of the native valve.
The present invention will be more fully understood from the following detailed description of applications thereof, taken together with the drawings, in which:
Prosthetic valve 10 comprises a collapsible flexible support frame 20, which is at least partially covered by a covering 22. The prosthetic valve is shaped so as to define a downstream skirt 24 and an upstream annular skirt 26. The downstream skirt is configured to be placed at native valve 12, such that the downstream skirt passes through the orifice of the native valve and extends towards, and, typically partially into, a ventricle 28. The downstream skirt typically pushes aside and presses against native leaflets 30 of native valve 12, which are typically left in place during and after implantation of the prosthetic valve. The upstream annular skirt is configured to be placed around a native annulus 32 of the native valve, and to extend at least partially into an atrium 34 such that annular skirt rests against the native annulus. The annular skirt is typically too large to pass through the annulus, and may, for example, have an outer diameter of between 30 and 60 mm.
For some applications, collapsible support frame 20 comprises a stent, which comprises a plurality of struts. The struts may comprise, for example, a metal such as Nitinol or stainless steel. For some applications, covering 22 comprises a fabric, such as a woven fabric, e.g., Dacron. Covering 22 is typically configured to cover at least a portion of downstream skirt 24, and at least a portion of upstream annular skirt 26, such as the entire annular skirt (as shown in
Prosthetic valve 10 further comprises a plurality of valve leaflets 40, which may be artificial or tissue-based. The leaflets are typically coupled to an inner surface of the valve prosthesis, such as near the junction between the downstream and upstream skirts 24 and 26. The leaflets are coupled, e.g., sewn, to frame 20 and/or covering 22. For applications in which the prosthetic valve is configured to be implanted at the native mitral valve, the prosthetic valve typically comprises three leaflets 40, such as shown in
For some applications, such as shown in
Reference is now made to
As shown in
Subsequently, as shown in
These techniques enable the surgeon to readily bring the anchors to the appropriate sites of the upstream annular skirt, without the need for excessive imaging, such as fluoroscopy.
Reference is made to
As shown in
Subsequently, as shown in
For some applications, respective coupling, elements 74 are used to couple the skirt to the posts of the anchors. The coupling elements may be passed over elongated members 70. For example, the coupling elements may be shaped as discs with inwardly-facing teeth that engage the posts, and prevent removal of the disc from the posts. The elongated members are subsequently decoupled from anchors 50. For example, a cutting tool may be used to decouple the elongated members from the anchors; the cutting tool may be passed through catheter 72, and/or guided along the elongated member. Alternatively, the elongated members may be looped through the anchors, such that both ends of each elongated member remain outside of the patient's body. The surgeon decouples the elongated member from the anchor by releasing one end of the elongated member and pulling on the other end, until the elongated member is drawn from the anchor.
Reference is made to
For some applications, in order to tense ventricular cords 102, prosthetic valve 10 and upstream portions 110 of the cords are configured to provide one-way upstream motion of the cords with respect to the prosthetic valve, and to prevent distal motion of the cords. For example, upstream portions 110 of the cords may be shaped so as to define a one-way ratchet, which can pass through upstream annular skirt 26 in an upstream direction, but not in a downstream direction. After the cords have been anchored to the ventricular sites and the prosthetic valve has been placed in position at the native annulus, the surgeon pulls upstream on the upstream ends of the cords, in order to tense the cords. Optionally, as shown in
For some applications, in order to provide access to anchors 50 during coupling of the anchors to the ventricular sites, the surgeon first introduces the anchors and cords into the ventricle, thereafter couples the anchors to the ventricular sites, and subsequently positions the prosthetic valve at the native annulus. The cords may pass between downstream skirt 24 and native leaflets 30 (as shown in
For some applications, as shown in
For some applications, the coupling techniques described with reference to
For some applications, instead of being coupled to upstream annular skirt 26 (as shown in
Reference is made to
For some applications, as shown in
For some applications, as shown in
Reference is made to
For some applications, valve prosthesis 10 further comprises a contracting housing 154. Typically, a first end of anchoring member 152 is fixed to the contracting housing, and a second end of the anchoring member passes through a channel of the contracting housing. Pulling on the second end of the anchoring member tightens the anchoring member around the native leaflets. For some applications, an upstream portion of the anchoring member is shaped so as to define a ratchet, which allows tightening, but not loosening, of the anchoring member.
Reference is made to
Prosthetic valve 10 is configured to assume two states: (a) an extended, unlocked state 182, shown as configuration “A” of
During an implantation procedure, prosthetic valve 10 initially assumes extended, unlocked state 182. The prosthetic valve is advanced to native valve 12 in this unlocked state, and anchoring arms 180 are positioned such that native leaflets 30 are between the anchoring arms and the body of downstream skirt 24. The surgeon causes the prosthetic valve to assume contracted, locked state 184. In locked state 184 the anchoring arms squeeze and grasp native leaflets 30 and a portion of native annulus 32 between the anchoring arms, the body of the downstream skirt 24, and upstream annular skirt 26. In this application, upstream annular skirt 26 may comprise relative short upstream arms 194, which may correspond to and be aligned with anchoring arms 180 of downstream skirt 24. Optionally, upstream arms 194 may comprise one or more spikes 196, which are configured to pierce native annulus 32 in order to aid with anchoring.
As best seen in
For some applications, a procedure using tool 200 begins with the introduction of catheter 220, as shown in
As shown in
As shown in
Upstream pushing adaptor 212 is retracted into catheter 220, and downstream pulling adaptor 214 is retracted into downstream adaptor holder 224, as shown in
Although prosthetic valve 10 has been described herein as being configured for implantation in and/or at least partial replacement of a native atrioventricular valve, for some applications prosthetic valve 10 is configured for implantation in and/or at least partial replacement of a native aortic valve or a native pulmonary valve, mutatis mutandis.
It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described hereinabove. Rather, the scope of the present invention includes both combinations and subcombinations of the various features described hereinabove, as well as variations and modifications thereof that are not in the prior art, which would occur to persons skilled in the art upon reading the foregoing description.
The present application is a divisional application of U.S. patent application Ser. No. 13/044,694 to Hacohen, filed on Mar. 10, 2011, entitled “Prosthetic mitral valve with tissue anchors,” which published as US 2011/0224785, and which claims priority from U.S. Provisional Application 61/312,412, filed Mar. 10, 2010, entitled, “Prosthetic mitral valve with tissue anchors,” which is assigned to the assignee of the present application and is incorporated herein by reference. The present application is related to an international patent application entitled, “Prosthetic mitral valve with tissue anchors,” filed on even date herewith, which published as WO 2011/111047, and which is assigned to the assignee of the present application and is incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
5405378 | Strecker | Apr 1995 | A |
5443500 | Sigwart | Aug 1995 | A |
5647857 | Anderson et al. | Jul 1997 | A |
5765682 | Bley et al. | Jun 1998 | A |
5873906 | Lau et al. | Feb 1999 | A |
5980565 | Jayaraman | Nov 1999 | A |
6019787 | Richard et al. | Feb 2000 | A |
6165210 | Lau et al. | Dec 2000 | A |
6193745 | Fogarty et al. | Feb 2001 | B1 |
6334873 | Lane et al. | Jan 2002 | B1 |
6350278 | Lenker et al. | Feb 2002 | B1 |
6352561 | Leopold et al. | Mar 2002 | B1 |
6454799 | Schreck | Sep 2002 | B1 |
6458153 | Bailey | Oct 2002 | B1 |
6551350 | Thornton et al. | Apr 2003 | B1 |
6558396 | Inoue | May 2003 | B1 |
6767362 | Schreck | Jul 2004 | B2 |
6821297 | Snyders | Nov 2004 | B2 |
7018406 | Seguin | Mar 2006 | B2 |
7101396 | Artof et al. | Sep 2006 | B2 |
7137184 | Schreck | Nov 2006 | B2 |
7201772 | Schwammenthal | Apr 2007 | B2 |
7329279 | Haug et al. | Feb 2008 | B2 |
7374573 | Gabbay | May 2008 | B2 |
7377938 | Sarac et al. | May 2008 | B2 |
7429269 | Schwammenthal | Sep 2008 | B2 |
7510575 | Spenser et al. | Mar 2009 | B2 |
7585321 | Cribier | Sep 2009 | B2 |
7625403 | Krivoruchko | Dec 2009 | B2 |
7648528 | Styrc | Jan 2010 | B2 |
7682380 | Thornton et al. | Mar 2010 | B2 |
7717952 | Case et al. | May 2010 | B2 |
7748389 | Salahieh et al. | Jul 2010 | B2 |
7758632 | Hojeibane et al. | Jul 2010 | B2 |
7780726 | Seguin | Aug 2010 | B2 |
7837727 | Goetz | Nov 2010 | B2 |
7942927 | Kaye et al. | May 2011 | B2 |
7955377 | Melsheimer | Jun 2011 | B2 |
7959672 | Salahieh et al. | Jun 2011 | B2 |
8002826 | Seguin | Aug 2011 | B2 |
8016882 | Macoviak et al. | Sep 2011 | B2 |
8048138 | Sullivan et al. | Nov 2011 | B2 |
8048153 | Salahieh | Nov 2011 | B2 |
8062355 | Figulla | Nov 2011 | B2 |
8070802 | Lamphere | Dec 2011 | B2 |
8092520 | Quadri | Jan 2012 | B2 |
8109996 | Stacchino et al. | Feb 2012 | B2 |
8118866 | Herrmann | Feb 2012 | B2 |
8142492 | Forster et al. | Mar 2012 | B2 |
8142496 | Berreklouw | Mar 2012 | B2 |
8163008 | Wilson et al. | Apr 2012 | B2 |
8172898 | Alferness et al. | May 2012 | B2 |
8182528 | Salahieh | May 2012 | B2 |
8216301 | Bonhoeffer et al. | Jul 2012 | B2 |
8267988 | Hamer et al. | Sep 2012 | B2 |
8303653 | Bonhoeffer et al. | Nov 2012 | B2 |
8337541 | Quadri et al. | Dec 2012 | B2 |
8343213 | Salahieh et al. | Jan 2013 | B2 |
8366767 | Zhang | Feb 2013 | B2 |
8403981 | Forster et al. | Mar 2013 | B2 |
8403983 | Quadri et al. | Mar 2013 | B2 |
8408214 | Spenser | Apr 2013 | B2 |
8414644 | Quadri et al. | Apr 2013 | B2 |
8425593 | Braido et al. | Apr 2013 | B2 |
8444689 | Zhang | May 2013 | B2 |
8449599 | Chau et al. | May 2013 | B2 |
8454686 | Alkhatib | Jun 2013 | B2 |
8540767 | Zhang | Sep 2013 | B2 |
8545544 | Spenser et al. | Oct 2013 | B2 |
8551161 | Dolan | Oct 2013 | B2 |
8562672 | Bonhoeffer et al. | Oct 2013 | B2 |
8579964 | Lane et al. | Nov 2013 | B2 |
8579965 | Bonhoeffer et al. | Nov 2013 | B2 |
8585755 | Chau et al. | Nov 2013 | B2 |
8585756 | Bonhoeffer et al. | Nov 2013 | B2 |
8591570 | Revuelta et al. | Nov 2013 | B2 |
8623075 | Murray, III et al. | Jan 2014 | B2 |
8628569 | Benichou et al. | Jan 2014 | B2 |
8628570 | Seguin | Jan 2014 | B2 |
8652203 | Quadri et al. | Feb 2014 | B2 |
8679174 | Ottma et al. | Mar 2014 | B2 |
8685086 | Navia et al. | Apr 2014 | B2 |
8728155 | Montorfano et al. | May 2014 | B2 |
8747460 | Tuval et al. | Jun 2014 | B2 |
8771345 | Tuval et al. | Jul 2014 | B2 |
8784472 | Eidenschink | Jul 2014 | B2 |
8784481 | Alkhatib et al. | Jul 2014 | B2 |
8795355 | Alkhatib | Aug 2014 | B2 |
8795356 | Quadri et al. | Aug 2014 | B2 |
8795357 | Yohanan et al. | Aug 2014 | B2 |
8808366 | Braido et al. | Aug 2014 | B2 |
8840664 | Karapetian et al. | Sep 2014 | B2 |
8852261 | White | Oct 2014 | B2 |
8852272 | Gross | Oct 2014 | B2 |
8870948 | Erzberger et al. | Oct 2014 | B1 |
8870949 | Rowe | Oct 2014 | B2 |
8894702 | Quadri et al. | Nov 2014 | B2 |
8906083 | Obermiller et al. | Dec 2014 | B2 |
8911455 | Quadri et al. | Dec 2014 | B2 |
8911489 | Ben-Muvhar | Dec 2014 | B2 |
8932343 | Alkhatib et al. | Jan 2015 | B2 |
8961595 | Alkhatib | Feb 2015 | B2 |
8979922 | Jayasinghe | Mar 2015 | B2 |
8986373 | Chau et al. | Mar 2015 | B2 |
8992608 | Haug et al. | Mar 2015 | B2 |
8998982 | Richter et al. | Apr 2015 | B2 |
9005273 | Salahieh et al. | Apr 2015 | B2 |
9023100 | Quadri et al. | May 2015 | B2 |
9034032 | McLean | May 2015 | B2 |
9034033 | McLean | May 2015 | B2 |
9039757 | McLean | May 2015 | B2 |
9050188 | Schweich, Jr. et al. | Jun 2015 | B2 |
9072603 | Tuval et al. | Jul 2015 | B2 |
9084676 | Chau et al. | Jul 2015 | B2 |
9125738 | Figulla et al. | Sep 2015 | B2 |
9125740 | Morriss et al. | Sep 2015 | B2 |
9132006 | Spenser et al. | Sep 2015 | B2 |
9138312 | Tuval et al. | Sep 2015 | B2 |
9173738 | Murray, III et al. | Nov 2015 | B2 |
9220594 | Braido et al. | Dec 2015 | B2 |
9226820 | Braido et al. | Jan 2016 | B2 |
9226839 | Kariniemi et al. | Jan 2016 | B1 |
9232995 | Kovalsky et al. | Jan 2016 | B2 |
9241791 | Braido et al. | Jan 2016 | B2 |
9241794 | Braido et al. | Jan 2016 | B2 |
9248014 | Lane et al. | Feb 2016 | B2 |
9289290 | Alkhatib et al. | Mar 2016 | B2 |
9289291 | Gorman, III et al. | Mar 2016 | B2 |
9295550 | Nguyen et al. | Mar 2016 | B2 |
9295552 | McLean et al. | Mar 2016 | B2 |
9301836 | Buchbinder et al. | Apr 2016 | B2 |
D755384 | Pesce et al. | May 2016 | S |
9326852 | Spenser | May 2016 | B2 |
9421098 | Gifford, III et al. | Aug 2016 | B2 |
9427316 | Schweich, Jr. et al. | Aug 2016 | B2 |
9532870 | Cooper et al. | Jan 2017 | B2 |
20010056295 | Solem | Dec 2001 | A1 |
20020099436 | Thornton et al. | Jul 2002 | A1 |
20040122503 | Campbell et al. | Jun 2004 | A1 |
20040143315 | Bruun et al. | Jul 2004 | A1 |
20040249433 | Freitag | Dec 2004 | A1 |
20040260394 | Douk et al. | Dec 2004 | A1 |
20050038494 | Eidenschink | Feb 2005 | A1 |
20050080430 | Wright, Jr. et al. | Apr 2005 | A1 |
20050137688 | Salahieh et al. | Jun 2005 | A1 |
20050137689 | Salahieh et al. | Jun 2005 | A1 |
20050137695 | Salahieh et al. | Jun 2005 | A1 |
20050143809 | Salahieh et al. | Jun 2005 | A1 |
20050154443 | Linder et al. | Jul 2005 | A1 |
20050240200 | Bergheim | Oct 2005 | A1 |
20060015171 | Armstrong | Jan 2006 | A1 |
20060020333 | Lashinski et al. | Jan 2006 | A1 |
20060089627 | Burnett et al. | Apr 2006 | A1 |
20060178700 | Quinn | Aug 2006 | A1 |
20060195183 | Navia et al. | Aug 2006 | A1 |
20060212111 | Case et al. | Sep 2006 | A1 |
20060259137 | Artof et al. | Nov 2006 | A1 |
20060271166 | Thill et al. | Nov 2006 | A1 |
20070055340 | Pryor | Mar 2007 | A1 |
20070198077 | Cully et al. | Aug 2007 | A1 |
20070213813 | Von Segesser et al. | Sep 2007 | A1 |
20080071363 | Tuval et al. | Mar 2008 | A1 |
20080071369 | Tuval et al. | Mar 2008 | A1 |
20080082083 | Forde et al. | Apr 2008 | A1 |
20080097595 | Gabbay | Apr 2008 | A1 |
20080140003 | Bei et al. | Jun 2008 | A1 |
20080167705 | Agnew | Jul 2008 | A1 |
20080234814 | Salahieh | Sep 2008 | A1 |
20080255580 | Hoffman et al. | Oct 2008 | A1 |
20080294234 | Hartley et al. | Nov 2008 | A1 |
20090005863 | Goetz et al. | Jan 2009 | A1 |
20090054969 | Salahieh et al. | Feb 2009 | A1 |
20090112159 | Slattery et al. | Apr 2009 | A1 |
20090299449 | Styrc | Dec 2009 | A1 |
20090306768 | Quadri | Dec 2009 | A1 |
20100076548 | Konno | Mar 2010 | A1 |
20100131054 | Tuval et al. | May 2010 | A1 |
20100137979 | Tuval et al. | Jun 2010 | A1 |
20100161036 | Pintor et al. | Jun 2010 | A1 |
20100161042 | Maisano et al. | Jun 2010 | A1 |
20100179649 | Richter et al. | Jul 2010 | A1 |
20100234940 | Dolan | Sep 2010 | A1 |
20110071626 | Wright et al. | Mar 2011 | A1 |
20110077730 | Fentster | Mar 2011 | A1 |
20110098525 | Kermode | Apr 2011 | A1 |
20110137397 | Chau et al. | Jun 2011 | A1 |
20110208283 | Rust | Aug 2011 | A1 |
20110208298 | Tuval et al. | Aug 2011 | A1 |
20110218619 | Benichou et al. | Sep 2011 | A1 |
20110224785 | Hacohen | Sep 2011 | A1 |
20110282439 | Thill et al. | Nov 2011 | A1 |
20110319989 | Lane et al. | Dec 2011 | A1 |
20120022633 | Olson et al. | Jan 2012 | A1 |
20120078357 | Conklin | Mar 2012 | A1 |
20120101572 | Kovalsky et al. | Apr 2012 | A1 |
20120123511 | Brown | May 2012 | A1 |
20120130473 | Norris et al. | May 2012 | A1 |
20120130474 | Buckley | May 2012 | A1 |
20120130475 | Shaw | May 2012 | A1 |
20120165915 | Melsheimer et al. | Jun 2012 | A1 |
20120179244 | Schankereli et al. | Jul 2012 | A1 |
20120296360 | Norris et al. | Nov 2012 | A1 |
20120310328 | Olson et al. | Dec 2012 | A1 |
20120330408 | Hillukka et al. | Dec 2012 | A1 |
20130006347 | McHugo | Jan 2013 | A1 |
20130018450 | Hunt | Jan 2013 | A1 |
20130041451 | Patterson et al. | Feb 2013 | A1 |
20130123896 | Bloss et al. | May 2013 | A1 |
20130123900 | Eblacas et al. | May 2013 | A1 |
20130150945 | Crawford et al. | Jun 2013 | A1 |
20130150956 | Yohanan et al. | Jun 2013 | A1 |
20130158647 | Norris et al. | Jun 2013 | A1 |
20130166017 | Cartledge et al. | Jun 2013 | A1 |
20130166022 | Conklin | Jun 2013 | A1 |
20130172978 | Vidlund et al. | Jul 2013 | A1 |
20130211501 | Buckley et al. | Aug 2013 | A1 |
20130245742 | Norris | Sep 2013 | A1 |
20130297013 | Klima et al. | Nov 2013 | A1 |
20130310928 | Morriss | Nov 2013 | A1 |
20130325114 | McLean et al. | Dec 2013 | A1 |
20130331929 | Mitra et al. | Dec 2013 | A1 |
20140005778 | Buchbinder | Jan 2014 | A1 |
20140018911 | Zhou et al. | Jan 2014 | A1 |
20140031928 | Murphy et al. | Jan 2014 | A1 |
20140046430 | Shaw | Feb 2014 | A1 |
20140081376 | Burkart et al. | Mar 2014 | A1 |
20140106951 | Brandon | Apr 2014 | A1 |
20140120287 | Jacoby et al. | May 2014 | A1 |
20140121763 | Duffy et al. | May 2014 | A1 |
20140135894 | Norris et al. | May 2014 | A1 |
20140135895 | Andress et al. | May 2014 | A1 |
20140142681 | Norris | May 2014 | A1 |
20140148891 | Johnson | May 2014 | A1 |
20140163690 | White | Jun 2014 | A1 |
20140172069 | Roeder et al. | Jun 2014 | A1 |
20140188210 | Beard et al. | Jul 2014 | A1 |
20140188221 | Chung et al. | Jul 2014 | A1 |
20140194983 | Kovalsky et al. | Jul 2014 | A1 |
20140207231 | Hacohen et al. | Jul 2014 | A1 |
20140214159 | Vidlund et al. | Jul 2014 | A1 |
20140222163 | Xu et al. | Aug 2014 | A1 |
20140249622 | Carmi et al. | Sep 2014 | A1 |
20140257467 | Lane et al. | Sep 2014 | A1 |
20140257475 | Gross | Sep 2014 | A1 |
20140257476 | Montorfano et al. | Sep 2014 | A1 |
20140277358 | Slazas | Sep 2014 | A1 |
20140277409 | Bortlein et al. | Sep 2014 | A1 |
20140277427 | Ratz et al. | Sep 2014 | A1 |
20140296962 | Cartledge et al. | Oct 2014 | A1 |
20140324164 | Gross et al. | Oct 2014 | A1 |
20140343670 | Bakis | Nov 2014 | A1 |
20140358224 | Tegels et al. | Dec 2014 | A1 |
20140379065 | Johnson et al. | Dec 2014 | A1 |
20140379074 | Spence et al. | Dec 2014 | A1 |
20140379076 | Vidlund et al. | Dec 2014 | A1 |
20150045881 | Lim | Feb 2015 | A1 |
20150094802 | Buchbinder | Apr 2015 | A1 |
20150127097 | Neumann et al. | May 2015 | A1 |
20150142103 | Vidlund | May 2015 | A1 |
20150164640 | McLean et al. | Jun 2015 | A1 |
20150173896 | Richter et al. | Jun 2015 | A1 |
20150173897 | Raanani | Jun 2015 | A1 |
20150272730 | Melnick et al. | Oct 2015 | A1 |
20150327994 | Morriss | Nov 2015 | A1 |
20150328000 | Ratz et al. | Nov 2015 | A1 |
20160095700 | Righini | Apr 2016 | A1 |
20160106539 | Buchbinder et al. | Apr 2016 | A1 |
20160220367 | Barrett | Aug 2016 | A1 |
20160242902 | Morriss et al. | Aug 2016 | A1 |
20160310268 | Oba et al. | Oct 2016 | A1 |
20160324640 | Gifford, III et al. | Nov 2016 | A1 |
Number | Date | Country |
---|---|---|
2006070372 | Jul 2006 | WO |
2006089236 | Aug 2006 | WO |
2007059252 | May 2007 | WO |
2008029296 | Mar 2008 | WO |
2008070797 | Jun 2008 | WO |
2008103722 | Aug 2008 | WO |
2009091509 | Jul 2009 | WO |
2012024428 | Feb 2012 | WO |
2012177942 | Dec 2012 | WO |
2013059747 | Apr 2013 | WO |
2013078497 | Jun 2013 | WO |
2014022124 | Feb 2014 | WO |
2014145338 | Sep 2014 | WO |
2014164364 | Oct 2014 | WO |
2015173794 | Nov 2015 | WO |
2016093877 | Jun 2016 | WO |
Entry |
---|
USPTO RR dated Jan. 20, 2016 in connection with U.S. Appl. No. 14/161,921. |
USPTO NFOA dated Dec. 10, 2015 in connection with U.S. Appl. No. 14/237,258. |
USPTO NFOA dated Jan. 21, 2016 in connection with U.S. Appl. No. 14/237,264. |
Francesco Maisano, MD, FESC; Valtech Cardiovalve: Novel Design Feature and Clinical Update; CRF Cardiovascular Research Foundation; TCT2015; 10 pages. |
An International Search Report and Written Opinion both dated Oct. 19, 2015, PCT/IL2015/050792. |
USPTO NFOA dated Jun. 30, 2015 in connection with U.S. Appl. No. 14/522,987. |
U.S. Appl. No. 61/312,412, filed Mar. 10, 2010. |
International Search Report and Written Opinion both dated May 30, 2016; PCT/IL2016/050125. |
USPTO NFOA dated Jul. 1, 2016 in connection with U.S. Appl. No. 14/161,921. |
USPTO RR dated Sep. 26, 2016 in connection with U.S. Appl. No. 14/763,004. |
Saturn Project—a novel solution for transcatheter heart valve replacement specifically designed to address clinical therapeutic needs on mitral valve; Dec. 2016. |
Righini presentation EuroPCR May 2015 (Saturn)—(downloaded from; https://www.pcronline.com/Cases-resourcesimages/Resources/Course-videos-slides/2015/Cardiovascularinnovation-pipeline-Mitral-and-triscupid-valve-interventions.). |
EPO Office Action dated Feb. 10, 2017; Appln. 12 821 522.5-1651. |
UK Office Action dated Feb. 8, 2017; UK Appln. 1613219.3. |
USPTO NFOA dated Feb. 7, 2017 in connection with U.S. Appl. No. 14/689,608. |
Number | Date | Country | |
---|---|---|---|
20150157457 A1 | Jun 2015 | US |
Number | Date | Country | |
---|---|---|---|
61312412 | Mar 2010 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13044694 | Mar 2011 | US |
Child | 14626267 | US |